Literature DB >> 25144338

The Helicobacter pylori resistance rate to clarithromycin in Iran.

Shahrbanoo Keshavarz Azizi Raftar1, Rezvan Moniri, Mahmood Saffari, Mohsen Razavi Zadeh, Abbas Arj, Seyed Gholam Abbas Mousavi, Hamed Mirzaei Ghazi Kalayeh, Kamran Dastehgoli.   

Abstract

BACKGROUND: Clarithromycin is the most commonly suggested antibiotic in Helicobacter pylori eradication regimens. Increasing antibiotic resistance rate to clarithromycin is the main reason for therapeutic failure. The resistance is associated with mutations in the 23S rRNA gene. AIM: The purpose of this study was to determine the clarithromycin resistance rate of isolated H. pylori strains from referral patients in Kashan, Iran.
METHODS: In total 95 H. pylori strains isolated from gastric mucosa of 246 patients with different clinical signs underwent gastroscopy in Kashan, Iran in 2013. The Epsilometer test was used to determine the minimum inhibitory concentrations (MICs) of clarithromycin (CLR) in isolated H. pylori strains. Occurrence of mutation in 23S rRNA gene of clarithromycin-resistant strains was investigated with polymerase chain reaction-sequencing method.
RESULTS: Antibiotic susceptibility pattern showed that 32 strains (33.7%) were resistant to clarithromycin (MICs ≥1 μg/ml), 33.7% were intermediate resistant, while 31 of H. pylori strains (32.6%) were susceptible. The 23S rRNA gene mutations at positions A2143G and A2142G were detected in H. pylori clarithromycin-resistant strains.
CONCLUSION: The resistance rate to clarithromycin in Iran is high. H. pylori clarithromycin-resistant strains were not associated with sex, age, and disease. The A2143G mutation in clarithromycin-resistant H. pylori strains was the predominant finding.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25144338     DOI: 10.1089/mdr.2014.0104

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  6 in total

1.  Investigation of Clarithromycin Resistance-Associated Mutations and Virulence Genotypes of Helicobacter pylori Isolated from Iranian Population: A Cross-Sectional Study.

Authors:  Helia Alavifard; Nasrin Mirzaei; Abbas Yadegar; Kaveh Baghaei; Sinéad Marian Smith; Amir Sadeghi; Mohammad Reza Zali
Journal:  Curr Microbiol       Date:  2020-11-30       Impact factor: 2.188

Review 2.  Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review.

Authors:  Reza Ghotaslou; Hamed Ebrahimzadeh Leylabadlo; Yalda Mohammadzadeh Asl
Journal:  World J Methodol       Date:  2015-09-26

3.  Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.

Authors:  Hassan Salmanroghani; Massoud Mirvakili; Mahmud Baghbanian; Roham Salmanroghani; Golshid Sanati; Pouria Yazdian
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

Review 4.  Eradication of Helicobacter Pylori in Iran: A Review.

Authors:  Hafez Fakheri; Mehdi Saberi Firoozi; Zohreh Bari
Journal:  Middle East J Dig Dis       Date:  2017-09-21

5.  Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in México.

Authors:  Margarita Camorlinga-Ponce; Alejandro Gómez-Delgado; Emmanuel Aguilar-Zamora; Roberto C Torres; Silvia Giono-Cerezo; Antonio Escobar-Ogaz; Javier Torres
Journal:  Front Cell Infect Microbiol       Date:  2021-02-11       Impact factor: 5.293

6.  Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children.

Authors:  Karam-Ali Kasiri; Abolfazl Khoshdel; Afshin Karimi; Morteza Sedehi; Niloufar Kasiri
Journal:  J Adv Pharm Technol Res       Date:  2017 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.